Product Code: RP-ID-10012848 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10012848
Market Overview:
Global Indian Nasal Spray Market Size study, by Product (Decongestion Nasal Spray, Salt Water Solution/Saline Nasal Spray, Steroid Nasal Spray). by Availability (Prescribed, Over the Counter), by Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitors, Anticholinergic) and by Regional Forecasts 2018-2025
Global Indian Nasal Spray Market to reach USD 1.65 billion by 2025.
Global Indian Nasal Spray Market valued approximately USD 786 million in 2017 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2018-2025. The primary factors driving the market growth of Indian Nasal include increasing cases of allergic rhinitis and infections, changing lifestyle of people, rising level of pollution, increasing research and development of generic nasal spray drugs, rising awareness among the people, better alternate for other mode of drug delivery, rising demand for self-administration, improving patient compliance, increasing acceptability, and more effective as compared to other forms. About 20-30% of Indian population suffers from at least one allergic disease. On the other hand, addiction to nasal sprays, temporary relief, pungent smell, sneezing, nasal irritation, runny nose, bleeding from nose, and regulatory reforms are some of the major factors which may restraints the growth of nasal spray market.
The regional analysis of Global Indian Nasal Spray Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
 Decongestion Nasal Spray
 Salt Water Solution/Saline Nasal Spray
 Steroid Nasal Spray
By Availability:
 Prescribed
 Over the Counter
By Therapeutic Class:
 Antihistamine
 Nasal Steroids
 Mast Cell Inhibitor
 Anticholinergic
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Glaxo Smith Kline, Ranbaxy., Cipla, Lupin, Sun pharmaceuticals Industries Ltd., Zydus Cadiala Pharmaceuticals, Macleods and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Indian Nasal Spray Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Ranbaxy.
Cipla
Lupin
Sun pharmaceuticals Industries Ltd.
Zydus Cadiala Pharmaceuticals
Macleods
Related Reports
Proof of Quality & Reliability
